Literature DB >> 21425267

Axonal damage in multiple sclerosis.

Jeffery D Haines1, Matilde Inglese, Patrizia Casaccia.   

Abstract

Multiple sclerosis is a debilitating disease of the central nervous system that has been characteristically classified as an immune-mediated destruction of myelin, the protective coating on nerve fibers. Although the mechanisms responsible for the immune attack to central nervous system myelin have been the subject of intense investigation, more recent studies have focused on the neurodegenerative component, which is cause of clinical disability in young adults and appears to be only partially controlled by immunomodulatory therapies. Here, we review distinct, but not mutually exclusive, mechanisms of pathogenesis of axonal damage in multiple sclerosis patients that are either consequent to long-term demyelination or independent from it. We propose that the complexity of axonal degeneration and the heterogeneity of the underlying pathogenetic mechanisms should be taken into consideration for the design of targeted therapeutic intervention.
© 2011 Mount Sinai School of Medicine.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21425267      PMCID: PMC3142952          DOI: 10.1002/msj.20246

Source DB:  PubMed          Journal:  Mt Sinai J Med        ISSN: 0027-2507


  145 in total

Review 1.  Diffusion tensor imaging: concepts and applications.

Authors:  D Le Bihan; J F Mangin; C Poupon; C A Clark; S Pappata; N Molko; H Chabriat
Journal:  J Magn Reson Imaging       Date:  2001-04       Impact factor: 4.813

2.  The ups and downs of multiple sclerosis therapeutics.

Authors:  R Hohlfeld; H Wiendl
Journal:  Ann Neurol       Date:  2001-03       Impact factor: 10.422

3.  Transection of major histocompatibility complex class I-induced neurites by cytotoxic T lymphocytes.

Authors:  I Medana; M A Martinic; H Wekerle; H Neumann
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

4.  A comparison of the pathology of primary and secondary progressive multiple sclerosis.

Authors:  T Revesz; D Kidd; A J Thompson; R O Barnard; W I McDonald
Journal:  Brain       Date:  1994-08       Impact factor: 13.501

5.  Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients.

Authors:  C Bjartmar; G Kidd; S Mörk; R Rudick; B D Trapp
Journal:  Ann Neurol       Date:  2000-12       Impact factor: 10.422

6.  Relapses and progression of disability in multiple sclerosis.

Authors:  C Confavreux; S Vukusic; T Moreau; P Adeleine
Journal:  N Engl J Med       Date:  2000-11-16       Impact factor: 91.245

7.  Diffusion tensor magnetic resonance imaging in multiple sclerosis.

Authors:  M Filippi; M Cercignani; M Inglese; M A Horsfield; G Comi
Journal:  Neurology       Date:  2001-02-13       Impact factor: 9.910

8.  Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability.

Authors:  N De Stefano; S Narayanan; G S Francis; R Arnaoutelis; M C Tartaglia; J P Antel; P M Matthews; D L Arnold
Journal:  Arch Neurol       Date:  2001-01

9.  Multinuclear NMR studies on the energy metabolism of glial and neuronal cells.

Authors:  A Brand; C Richter-Landsberg; D Leibfritz
Journal:  Dev Neurosci       Date:  1993       Impact factor: 2.984

Review 10.  Epidemiology of multiple sclerosis.

Authors:  B G Weinshenker
Journal:  Neurol Clin       Date:  1996-05       Impact factor: 3.806

View more
  37 in total

1.  Analysis of White Matter Damage in Patients with Multiple Sclerosis via a Novel In Vivo MR Method for Measuring Myelin, Axons, and G-Ratio.

Authors:  A Hagiwara; M Hori; K Yokoyama; M Nakazawa; R Ueda; M Horita; C Andica; O Abe; S Aoki
Journal:  AJNR Am J Neuroradiol       Date:  2017-08-03       Impact factor: 3.825

Review 2.  Oligodendrocyte regeneration: Its significance in myelin replacement and neuroprotection in multiple sclerosis.

Authors:  Kelly A Chamberlain; Sonia E Nanescu; Konstantina Psachoulia; Jeffrey K Huang
Journal:  Neuropharmacology       Date:  2015-10-22       Impact factor: 5.250

Review 3.  Oligodendroglia: metabolic supporters of axons.

Authors:  Brett M Morrison; Youngjin Lee; Jeffrey D Rothstein
Journal:  Trends Cell Biol       Date:  2013-08-27       Impact factor: 20.808

4.  Multiple sclerosis patient-derived CSF induces transcriptional changes in proliferating oligodendrocyte progenitors.

Authors:  Jeffery D Haines; Oscar G Vidaurre; Fan Zhang; Ángela L Riffo-Campos; Josefa Castillo; Bonaventura Casanova; Patrizia Casaccia; Gerardo Lopez-Rodas
Journal:  Mult Scler       Date:  2015-05-06       Impact factor: 6.312

5.  Scaffold Ranking and Positional Scanning Identify Novel Neurite Outgrowth Promoters with Nanomolar Potency.

Authors:  Hassan Al-Ali; Ginamarie Debevec; Radleigh G Santos; Richard A Houghten; Jennifer C Davis; Adel Nefzi; Vance P Lemmon; John L Bixby; Marc A Giulianotti
Journal:  ACS Med Chem Lett       Date:  2018-09-24       Impact factor: 4.345

6.  Sensitivity analysis of the Poisson Nernst-Planck equations: a finite element approximation for the sensitive analysis of an electrodiffusion model.

Authors:  Ibrahima Dione; Nicolas Doyon; Jean Deteix
Journal:  J Math Biol       Date:  2018-09-05       Impact factor: 2.259

7.  An interferon-β-resistant and NLRP3 inflammasome-independent subtype of EAE with neuronal damage.

Authors:  Makoto Inoue; Po-Han Chen; Stephen Siecinski; Qi-Jing Li; Chunlei Liu; Lawrence Steinman; Simon G Gregory; Eric Benner; Mari L Shinohara
Journal:  Nat Neurosci       Date:  2016-11-07       Impact factor: 24.884

8.  Targeted metabolomics approach for identification of relapsing-remitting multiple sclerosis markers and evaluation of diagnostic models.

Authors:  Marat F Kasakin; Artem D Rogachev; Elena V Predtechenskaya; Vladimir J Zaigraev; Vladimir V Koval; Andrey G Pokrovsky
Journal:  Medchemcomm       Date:  2019-08-12       Impact factor: 3.597

Review 9.  Differential contribution of microglia and monocytes in neurodegenerative diseases.

Authors:  Caroline Baufeld; Elaine O'Loughlin; Narghes Calcagno; Charlotte Madore; Oleg Butovsky
Journal:  J Neural Transm (Vienna)       Date:  2017-10-23       Impact factor: 3.575

10.  Cervical spinal demyelination with ethidium bromide impairs respiratory (phrenic) activity and forelimb motor behavior in rats.

Authors:  N L Nichols; A M Punzo; I D Duncan; G S Mitchell; R A Johnson
Journal:  Neuroscience       Date:  2012-11-14       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.